Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetWages, Salaries and Other
Ratios

Ptc Therapeutics (PTCT) Receivables - Net (2016 - 2025)

Ptc Therapeutics has reported Receivables - Net over the past 13 years, most recently at $181.6 million for Q4 2025.

  • Quarterly results put Receivables - Net at $181.6 million for Q4 2025, up 14.55% from a year ago — trailing twelve months through Dec 2025 was $181.6 million (up 14.55% YoY), and the annual figure for FY2025 was $181.6 million, up 14.55%.
  • Receivables - Net for Q4 2025 was $181.6 million at Ptc Therapeutics, down from $203.1 million in the prior quarter.
  • Over the last five years, Receivables - Net for PTCT hit a ceiling of $210.5 million in Q1 2025 and a floor of $78.8 million in Q2 2021.
  • Median Receivables - Net over the past 5 years was $163.3 million (2023), compared with a mean of $158.9 million.
  • Biggest five-year swings in Receivables - Net: soared 78.86% in 2021 and later dropped 2.08% in 2024.
  • Ptc Therapeutics' Receivables - Net stood at $110.5 million in 2021, then surged by 40.88% to $155.6 million in 2022, then rose by 3.35% to $160.8 million in 2023, then decreased by 1.41% to $158.6 million in 2024, then increased by 14.55% to $181.6 million in 2025.
  • The last three reported values for Receivables - Net were $181.6 million (Q4 2025), $203.1 million (Q3 2025), and $196.1 million (Q2 2025) per Business Quant data.